We previously reported exaggerated intimal thickening after arterial injury in immune-deficient Rag-l KO mice compared to wild-type mice. We evaluated the effect of normalizing immune functions through adoptive transfer of normal splenocytes, on mtimal thickening in Rag-l KO mice, which lack mature T and B cells.
Methods:
Injury in wild type (WT) mice, Rag-1 KO mice and Rag-l KO mice reconstituted with whole splenocyte (Rag-l KO T/B) was induced at 25 weeks of age using a carotid arterial cuff. Splenocytes for adoptive transfer were isolated from age-matched WT donors and injected i.v. (4-6 x 10' cells/mouse) into Rag-l KO mice 46 hours prior to injury. lntimal thickening was measured 21 days after cuffing. DNFB skin test and serum interferon-gamma (IFN) ELISA before injury verified T cell function. Serum IgG and IgM were measured by ELISA to confirm B cell function 21 days after cuffing. Splenocyte homing was verified using PCR.
Results: Splenocyte transfer resulted in partial normalization of immune functions and reduced intimal thickening in Rag-l KO mice (Table) . Rag-l KO T/B mice had positive DNFB skin test. PCR confirmed presence of transferred cells in the spleens of Rag-l KO T/B mice.
Conclusion:
Our results show that transferred splenocytes from immune-competent mice decrease intimal thickenmg after injury in immune deficient mice. These data sug gest that immune-modulation plays a significant role in intimal thickening after injury. 
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Regulation of Estrogen Receptor Subtypes on Vascular Cells
Pedro Gsraldes Martin G. Sirois, Jean-Franqois Tanguay, Montreal Heart Institute, Montreal, PQ, Canada
Background:
Most of the effects of estrogen on the cardiovascular system are mediated via estrogen receptor alpha (ERa) and beta (ERP) expressed in vascular tissues.
Recently, several studies have reported the expression of ER on the plasma membrane of vascular endothelial cells and smooth muscle cells. However, little is known regarding the distribution of each ER subtypes on these cells. Furthermore, few data exist concerning the effects of an acute or chronic treatment with 17.beta-estradiol (17PE) on the localization of each receptor.
Methods:
Porcine aortic endothelial cells (PAEC) and smooth muscle cells (PSMC) were treated with 17!3E (1O-9 to 1U'M) * selective antagonist (10.'M). Analysis of each ER subtype was performed using confocal microscopy by dividing the area of pixels of each ER bv the total area of the cell. Proteins from the cell membrane and the cvtoolasm were separated to evaluate the presence of each ER by Western Blot analysis.
Results:
In PBS-treated PAEC. ERa subtvoe was observed on the olasma membrane and in the perinuclear region. In contrast, ERP was located only in the perinuclear region.
Treatment of PAEC with 17!3E for 30 minutes increased the ERn and ERP labelling in the perinuclear region by up to 229% and 118%. respectively, as compared to PBS-treated cells. These effects were reversed by a pretreatment with selective antagonist prior to 17PE. Stimulation with 17PE for 24 hours did not significantly change the baseline distribution. On PSMC. ERP subtype was observed in the perinuclear region and on the plasma membrane while ERa was only located in the perinuclear region. Treatment of PSMC with 17PE for 30 minutes, but not for 24 hours, significantly increased both ERa and ERP visualization by up to 131% and 161% respectively as compared to PBStreated cells. Again, a pretreatment with a selective antagonist reversed these effects.
Conclusion:
A rapid treatment with 17PE regulates the localization of ERu and ERP on vascular cells. Our results suggest that 17QE induces a dense labelling of ER subtypes in the perinuclear region of PAEC and PSMC which appears to be transient.
Results:
Dietary supplementation with ALA decreased significantly CRP, SAA and IL-6 levels as shown in the The median decrease of CRP was 36%, of SAA 23.1% and of IL-6 10.5%. The decrease of inflammatory markers was independent of lipid changes. Dietary supplementation with LA did not affect significantly the levels of lipids, CRP. SAA and IL-6.
Conclusions:
Dietary supplementation with ALA decreases significantly CRP, SAA and IL-6 levels in dyslipidaemic pts. This anti-inflammatory effect may provide a possible additional mechanism for the beneficial effect of plant n-3 polyunsaturated fatty acids in primary and secondary prevention of CAD. P-zO.005). The prevalence of atherosclerotic plaques was higher in syndrome X patients than in control subjects (36.6% vs. lo%, P=O.Ol). Arterial stiffness was also significantly hioher in svndrome X oatients (13.5i5.6 vs. 10.9+3.9. P=O.O4). Hs-CRP levels were siq-" _ nificantly higher in syndrome X patients (2.6 11.7.4.51 vs. 1.5 [0.7-2.7) mg/L. P=O.O2) aid correlated with carotid IMT (Soeanan's rho=0.6: P=O.O03).
Patients with syndrome X have both increased mean common carotid artery IMT and higher hs-CRP serum levels, suggesting the presence of a chronic inflammation background which lead to vascular dysfunction and atherogenesis in these patbents. These results may have pathophysiological and therapeutic impkcations.
